Preparing the published article.
Company Profile: Hocoma Rehabilitation Technology
A source-based profile of Hocoma's Lokomat and Armeo systems, covering clinical workflows, model differences, international installation examples and practical rehabilitation procurement questions.
1. Company focus and rehabilitation setting
Hocoma AG is a Swiss rehabilitation-technology business within the DIH group. Its portfolio covers early rehabilitation, gait and balance, and arm and hand exercise. The company presents these systems as tools for rehabilitation professionals to integrate into clinical care. A buyer should begin with the movement task and service setting, since a walking-training installation and an upper-limb exercise device serve different purposes. Company identity; Rehabilitation portfolio.
2. Lokomat for repetitive gait training
Lokomat is a robotic gait-training system. Hocoma describes adjustable hip and knee movement, therapist-selected training parameters and game-like Augmented Performance Feedback. The listed product line includes LokomatPro and LokomatNanos, with FreeD and pediatric modules presented for LokomatPro. A proposal should identify the base model and each module; pediatric capability should not be assumed from the Lokomat name alone. Lokomat products and modules.
The published intended use concerns muscle strength and joint range of motion with the aim of improving walking. That intended purpose is not a promise that every patient will regain independent walking. Patient selection and contraindications belong in the clinical assessment. Lokomat intended use.
3. Armeo models address different upper-limb needs
ArmeoPower supplies adjustable robotic assistance for arm and hand exercises, ranging from substantial assistance to none according to the patient's activity. Hocoma describes joint-specific, two-dimensional and three-dimensional movement exercises and assessment functions. ArmeoPower functions.
ArmeoSpring Pro instead emphasizes continuous arm-weight support, a configurable orthosis and interactive exercises. Its reports include joint range-of-motion and reaching-workspace assessments. These features should not be conflated with ArmeoPower's powered movement assistance. Hocoma's legal notes distinguish severe-to-moderate upper-limb impairment for ArmeoPower from mild-to-moderate impairment for the listed Spring family. ArmeoSpring Pro; Model-specific indications.
4. Software and integration into daily therapy
Hocoma's Lokomat software page describes exercise planning, assessment reports and patient-report export to PDF or Excel. It also retains an explicitly dated Lokocontrol 6.5 upgrade section from 2017 and notes country and language availability. Buyers should request the currently supplied release and compatible hardware rather than treating this historical page as a current version specification. Software functions and version context.
Hocoma offers clinical integration consulting around patient populations, therapy organization and staff adoption. For a proposed installation, ask for a demonstration of the full workflow: patient setup, clinician adjustments, session documentation and cleaning between users. Define local staffing, training and handover responsibilities in the proposal. These are practical evaluation questions rather than assumed contents of every package. Clinical integration services.
5. Dated international installation examples
On 13 May 2025, Zahrawi Group reported installing LokomatPro at Sheikh Khalifa Hospital in Fujairah and Amana Healthcare in Abu Dhabi. It also reported an ArmeoSpring Pro installation at the Fujairah hospital. Zahrawi described its own service and physiotherapy-sales teams' participation, making this a firsthand supplier-side installation account. Dated installation report.
Hocoma independently lists Al Zahrawi in its UAE sales-and-service partner directory. This supports the commercial relationship, while the installation report documents only the named sites and date. Neither establishes comparative treatment outcomes, today's appointment availability or authorization of every configuration throughout the region. Official partner directory.
6. Device suitability and regional boundaries
Hocoma publishes separate indications, contraindications and risk factors for its devices. Its legal notes place responsibility for treatment suitability with the clinician. Procurement should therefore obtain the exact model's current local instructions, patient-interface sizing limits, supported modules and applicable market documentation before finalizing a clinical programme. A distributor listing or international case story is not a substitute for those records. Device-specific legal and clinical notes.
Ask the supplier to confirm installation clearances, transfer equipment, floor and electrical requirements, accessible emergency controls and compatibility with the intended patient group. Agree how contraindication screening and escalation will be handled by qualified staff. This profile does not prescribe exercises or determine an individual's eligibility.
7. Service planning and commercial contact
Hocoma publishes regional service centers, remote diagnostics, preventive maintenance and different service packages. Its maintenance table distinguishes device generations: for example, it lists different intervals for LokomatPro V6 and earlier V4/V5 models. Coverage is expressly subject to regional and device availability. Confirm the supplied unit's schedule, spare parts, travel charges and software support in writing. Technical services and maintenance.
Use Hocoma's sales-and-service directory to identify the responsible local supplier. It lists Swiss headquarters in Volketswil and Healthlink Holdings for Hong Kong. Request an itemized offer covering equipment, modules, installation, training, consumables, maintenance and documentation. Published contacts do not establish price, delivery time or a guaranteed service response. Regional commercial contacts.
8. Evidence limits and next steps
Reviewed on 10 September 2026. Product functions come from Hocoma; the dated deployment example comes from a listed partner reporting its own installation work. Marketing statements and testimonials are not independent evidence of clinical superiority. No universal certification, patient outcome, financial return or global product availability is inferred. Software and service terms require confirmation for the quoted configuration.
Explore medical robotics, Write a Robotics Buyer Brief and Robotics RFQ.